EP0575572A1 - Stabile Salze von (+)-(IS,2R)-2-[[N-(2-Hydroxylamino-2-oxoäthyl)N-methylamino]carbonyl]cyklohexan-1-carbonsäure - Google Patents

Stabile Salze von (+)-(IS,2R)-2-[[N-(2-Hydroxylamino-2-oxoäthyl)N-methylamino]carbonyl]cyklohexan-1-carbonsäure

Info

Publication number
EP0575572A1
EP0575572A1 EP92924726A EP92924726A EP0575572A1 EP 0575572 A1 EP0575572 A1 EP 0575572A1 EP 92924726 A EP92924726 A EP 92924726A EP 92924726 A EP92924726 A EP 92924726A EP 0575572 A1 EP0575572 A1 EP 0575572A1
Authority
EP
European Patent Office
Prior art keywords
carbonyl
carboxylic acid
salts
oxoethyl
alkaline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP92924726A
Other languages
English (en)
French (fr)
Inventor
Raffaello Giorgi
Alessandro Subissi
Luigi Turbanti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorio Guidotti SpA
Original Assignee
Laboratorio Guidotti SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorio Guidotti SpA filed Critical Laboratorio Guidotti SpA
Publication of EP0575572A1 publication Critical patent/EP0575572A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Definitions

  • This invention refers to novel salts of
  • (+)-(lS,2R)-2-[[N-(2-hydroxylamino-2-oxoethyl)-N-methyl-amino]carbonyl]cyclohexane- 1-carboxylic acid 1, (D.C.I. Idrapril) is a compound disclosed in the European Patent Application No. 89106304.2 as a novel ACE- inhibitory agent and therefore having antihypertensive activity.
  • This acid when kept exposed to the air in the normal environmental conditions of humidity and temperature, is subject to autodecomposition processes which give rise to impurities obviously incompatible with regard to a therapeutical use. Such degradation processes are also accelerated by a temperature increase of the acid kept in the above conditions.
  • novel salts according to this invention do not undergo to the autodecomposition and degradation processes previously mentioned.
  • the salts of the invention are stable compounds in the normal environmental conditions. Further the salts remain unchanged with time either kept as such or included (in a solid state) in a pharmaceutical preparation (tablets, pills, capsules, lyophilized compositions and the like) provided for their therapeutical use.
  • a pharmaceutical preparation tablettes, pills, capsules, lyophilized compositions and the like
  • the preparation of the compounds of the invention is based on a process characterized in that a compound, selected between
  • (+)-(1S,2R)-2-[[N-(2-hydroxyIamino-2-oxoethyl)-N-methylam ⁇ no]carbonyllcyclohexane-1 -carboxylic acid 1, is reacted with a compound selected among hydrates and carbonates or other suitable salts of alkaline and alkaline-earth metals, as defined in the present invention, as well as with organic bases, in an organic solvent or mixtures thereof with water, the reaction taking place, in the case of the starting product 2, contemporaneous hydrogenalysis of the protecting benzyl group with hydrogen at atmospheric pressure, in the presence of a suitable hydrogenation catalyst, the process being completed by isolating the desired salt of the acid.
  • Q is said hydroxide, or alkaline salt or calcium salt or an organic base.
  • the preferred hydrogenation catalyst is charcoal-supported Pd, but PtO 2 ,Rh/Al 2 O 3 and Ni-Raney can also be used.
  • propanol, tetrahydrofuran and dioxane are also suitable besides methanol and ethanol.
  • the catalyst was filtered and washed with awater/methanol (1/1) mixture (300 ml) and the filtrate, combined with the washings, concentrated under vacuum at 40°C until all the methanol has been removed.
  • the final suspension was cooled for 20 hours at 0-4°C and the precipitate was filtered and washed on the filter with 70 ml precooled water at 0-4°C.
  • (+)-(1S,2R)-2-[[N-(2-hydroxylamino-2-oxoethyI)-N-methylamino ⁇ carbonyl]cyclohexane-1 -carboxylic acid 1 were added and the mixture was further vigorously stirred for 60 minutes at 20°C.
  • the light suspension thus obtained was filtered (on paper) and the filtrate was concentrated under vacuum at 40°C to 200 mL.
  • the precipitated product was filtered and washed on filter with 50 mL of precooled water at 0-4°C.
  • Sample preparation Dissolve 20 mg of sample substance in 100 ml H 2 O/CH 3 CN 80/20
  • Table 1 shows the results, and in the first column, the data for the acid 1, tested in the same way, are reported.
  • the salts of the invention are also, within the suitable dosage ratios, practically comparable either for potency and for the activity lasting time to the acid 1.
  • the salts of this invention constitute the active ingredients for preparing pharmaceutical compositions both for oral and parenteral use.
  • compositions and preparations are made with the well-known pharmaceutical techniques and employing conventional excipients, carriers and solvents.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
EP92924726A 1991-12-23 1992-12-12 Stabile Salze von (+)-(IS,2R)-2-[[N-(2-Hydroxylamino-2-oxoäthyl)N-methylamino]carbonyl]cyklohexan-1-carbonsäure Withdrawn EP0575572A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI913448A IT1252708B (it) 1991-12-23 1991-12-23 Sali stabili dell'acido (+)-(1r,2s)-2((n-(2-idrossilammino-2-ossoetil)-n-metilammino)carbonil)cicloesan-1-carbossilico,ad attivita' ace inibitrice, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
ITMI91344 1991-12-23

Publications (1)

Publication Number Publication Date
EP0575572A1 true EP0575572A1 (de) 1993-12-29

Family

ID=11361409

Family Applications (1)

Application Number Title Priority Date Filing Date
EP92924726A Withdrawn EP0575572A1 (de) 1991-12-23 1992-12-12 Stabile Salze von (+)-(IS,2R)-2-[[N-(2-Hydroxylamino-2-oxoäthyl)N-methylamino]carbonyl]cyklohexan-1-carbonsäure

Country Status (26)

Country Link
EP (1) EP0575572A1 (de)
JP (1) JPH06506002A (de)
CN (1) CN1079474A (de)
AU (1) AU657591B2 (de)
BG (1) BG98050A (de)
BR (1) BR9205652A (de)
CA (1) CA2104372A1 (de)
CZ (1) CZ379692A3 (de)
EE (1) EE9400006A (de)
FI (1) FI933685A (de)
HR (1) HRP921454A2 (de)
HU (1) HUT69287A (de)
IT (1) IT1252708B (de)
LV (1) LV10426B (de)
MA (1) MA22749A1 (de)
MX (1) MX9207543A (de)
NZ (1) NZ245547A (de)
PL (1) PL169086B1 (de)
PT (1) PT101156A (de)
RU (1) RU2079489C1 (de)
SI (1) SI9200409A (de)
SK (1) SK379692A3 (de)
TN (1) TNSN92117A1 (de)
WO (1) WO1993013056A1 (de)
YU (1) YU110892A (de)
ZA (1) ZA9210004B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2817241A1 (fr) 2000-11-30 2002-05-31 Cebal Tube aluminium avec embout secable

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264860B1 (it) * 1993-06-21 1996-10-17 Guidotti & C Spa Labor Derivati di acidi cis- e trans-2(((2-(isdrossiammino)-2-ossoetil)- alchilammino)carbonil)cicloesancarbossilici
US5639746A (en) * 1994-12-29 1997-06-17 The Procter & Gamble Company Hydroxamic acid-containing inhibitors of matrix metalloproteases
US20100035991A1 (en) * 2006-09-28 2010-02-11 Mckeown Arlene Amide base salts of saha and polymorphis thereof
AU2021263319B2 (en) * 2020-04-27 2022-12-01 Carter-Hoffmann, Llc Door movement system for cabinet

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1224627B (it) * 1988-04-12 1990-10-04 Guidotti & C Spa Labor Ammidi di acidi ciclometilen_1,2_dicarbossilici adattivita' terapeutica, procedimenti per la loro preparazione e composizioni farmaceutiche che le contengono.

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9313056A1 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2817241A1 (fr) 2000-11-30 2002-05-31 Cebal Tube aluminium avec embout secable
WO2002044045A1 (fr) 2000-11-30 2002-06-06 Cebal S.A. Tube aluminium avec embout secable

Also Published As

Publication number Publication date
JPH06506002A (ja) 1994-07-07
ZA9210004B (en) 1993-12-13
AU3087192A (en) 1993-07-28
CN1079474A (zh) 1993-12-15
ITMI913448A1 (it) 1993-06-23
YU110892A (sh) 1996-01-08
HUT69287A (en) 1995-09-28
BR9205652A (pt) 1994-05-03
CA2104372A1 (en) 1993-06-24
MA22749A1 (fr) 1993-07-01
RU2079489C1 (ru) 1997-05-20
SI9200409A (en) 1993-09-30
HU9302389D0 (en) 1993-11-29
TNSN92117A1 (fr) 1993-06-08
BG98050A (bg) 1994-04-29
MX9207543A (es) 1993-08-01
IT1252708B (it) 1995-06-26
PT101156A (pt) 1994-06-30
WO1993013056A1 (en) 1993-07-08
EE9400006A (et) 1995-12-15
ITMI913448A0 (it) 1991-12-23
LV10426A (lv) 1995-02-20
HRP921454A2 (en) 1995-02-28
AU657591B2 (en) 1995-03-16
FI933685A0 (fi) 1993-08-20
CZ379692A3 (en) 1993-09-15
PL297118A1 (en) 1993-09-06
SK379692A3 (en) 1995-04-12
FI933685A (fi) 1993-08-20
LV10426B (en) 1995-08-20
NZ245547A (en) 1995-12-21
PL169086B1 (pl) 1996-05-31

Similar Documents

Publication Publication Date Title
JPS6051199A (ja) ２‐アザビシクロ〔３．１．０〕ヘキサン‐３‐カルボン酸の誘導体およびそれらの製法
NZ206574A (en) 1-(n-(1-carboxyalkyl)-alpha-aminoalkanoyl)-octahydro2s,3as,8as-cyclohepta(b)pyrrol-2-ylcarboxylic acid derivatives
EP0049658A1 (de) Substituierte Iminodisäuren, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
EP0477049A1 (de) Amido-3-Pyrazol-Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen
JPH04217949A (ja) アミノ酸誘導体
EP0079464A1 (de) Thiazolin-4-Carboxysäure Derivat, Verfahren zu seiner Herstellung und dieses enthaltendes Arzneimittel
FR2460291A1 (fr) Nouveaux tripeptides agissant sur le systeme nerveux central et leur procede de preparation
EP0340064A1 (de) Benzodiazepine, Verfahren und Zwischenprodukte zu ihrer Herstellung und ihre therapeutische Verwendung
US4134991A (en) Derivatives of 2-(3-phenyl-2-aminopropionyloxy)-acetic acid
EP0575572A1 (de) Stabile Salze von (+)-(IS,2R)-2-[[N-(2-Hydroxylamino-2-oxoäthyl)N-methylamino]carbonyl]cyklohexan-1-carbonsäure
EP0261017A1 (de) Aminosäureester von cycloaliphatischen Alkoholen, Verfahren zur Herstellung und Verwendung als Arzneimittel
JPH0559105B2 (de)
EP0383686A1 (de) Carboxyalkyl-ether von 2-Amino-7-hydroxytetralin
EP1899300A2 (de) Verfahren zur synthese des ace-inhibitors trandolapril
CA1231719A (en) Synthesis of phenyl alanine derivatives
SK179097A3 (en) Process for the production of enantiomerically-pure azetidine-2-carboxylic acid
US5420283A (en) Resolution of (R)-2-benzylsuccinic acid 4-[4-(N-t-butoxycarbonylmethylamino)-piperidine] amide
EP0057631B1 (de) ((Indol-3-yl)-3-amino-2-propionyloxy)-2-essigsäurederivate, Verfahren zu ihrer Herstellung und Heilmittel, die sie enthalten
US4370494A (en) Converting enzyme inhibitors
US4380644A (en) 2-Oxoimidazolidine derivatives
CN117858866A (zh) 用于制备色胺衍生物的方法
CA2369654A1 (en) N-substituted-n'-substituted urea derivatives and pharmaceutical compositions containing said derivatives
WO2001010851A1 (en) Process for the preparation of lysine-carboxyanhydride intermediates in the synthesis of lisinopril
JPH07504647A (ja) トリシクロ〔３．３．１．１３，７〕デカ−２−イル〔ｒ−（ｒ▲＊▼，ｒ▲＊▼）〕−３−（１ｈ−インドール−３−イル−メチル）−３−メチル−４．９−ジオキソ−７，１１−ジフェニル−１０−オキサ−２，５，８−トリアザウンデカン酸エステルの合成法
BE878763A (fr) Nouveaux aminoglucosides, leur preparation et leur application comme medicaments

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE

17P Request for examination filed

Effective date: 19940309

17Q First examination report despatched

Effective date: 19950516

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 19960726

RTI1 Title (correction)

Free format text: STABLE SALTS OF (+)-(1S,2R)-2- N-(2-HYDROXYLAMINO-2-OXOETHYL)-N-METHYL-AMINO CARBONYL CYCLOHEXANE-1-CARBOXYLIC ACID, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION